Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly/PCS consent order should require closed formulary P&T committee -- NACDS/Citizen Action letter.

Executive Summary

LILLY/PCS CONSENT ORDER SHOULD REQUIRE P&T COMMITTEE FOR CLOSED FORMULARY, NACDS and Citizen Action jointly requested in a June 23 letter to Federal Trade Commission Chairman Robert Pitofsky. Representatives of the 3 mil. member consumer group Citizen Action and the National Association of Chain Drug Stores met with Pitofsky and FTC Commissioner Janet Steiger the week of June 12 to urge FTC's reconsideration of the acquisition of the pharmacy benefit management firm PCS by Lilly from McKesson.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel